Market Cap 31.31B
Revenue (ttm) 3.20B
Net Income (ttm) 908.91M
EPS (ttm) N/A
PE Ratio 31.93
Forward PE 27.72
Profit Margin 28.45%
Debt to Equity Ratio 0.00
Volume 2,574,600
Avg Vol 3,473,072
Day's Range N/A - N/A
Shares Out 162.44M
Stochastic %K 100%
Beta 0.94
Analysts Strong Sell
Price Target $238.12

Company Profile

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics pla...

Industry: Health Information Services
Sector: Healthcare
Phone: 925 452 6500
Fax: 925 452 6504
Address:
4280 Hacienda Drive, Pleasanton, United States
donkeykongreturns
donkeykongreturns Jul. 3 at 4:39 AM
$VEEV An AI MLR tool is interesting, but adoption seems unlikely. MLR teams carrying significant compliance weight with FDA regs attached to literally every single word and image they review. 'Speed' is not the goal - accuracy and documentation are. Falcon MLR sounds like a release for the sake of having something to release. Copli is a different matter. That's a good idea (others have done it - not well) that Veeva specifically can execute on because of their MLR and Vault products. They house the content. This might be Veeva's competitive advantage post the complete ass kicking that IQVIA gave Veeva when they snatched the CRM market from them. Still think it ran to top of the range too quick, but Copli is interresting now that Veeva is no longer in the running for CRM. Their next few years are coming into focus.
0 · Reply
oceanbleu
oceanbleu Jul. 2 at 8:24 PM
$VEEV I alerted for a long at 168$ late last week and it is now up 14% from entry . The target 1 of 226.6$ is in sight. but first the daily 197.6 level must be breached and it can potentially still retest weekly accumulation zone as long as that pivot holds.
0 · Reply
IncelBull
IncelBull Jul. 2 at 7:46 PM
$LULU yogapants up along with $MELI $VEEV $PYPL $ADBE
0 · Reply
JFDI
JFDI Jul. 2 at 6:58 PM
$VEEV some strength off the lows
1 · Reply
Damiano18
Damiano18 Jul. 2 at 6:28 PM
$VEEV I love veev
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:43 PM
0 · Reply
lextrading
lextrading Jul. 2 at 3:35 PM
$VEEV since these alerts, it will be up almost 35% at the $203 pivot. I win. https://open.substack.com/pub/lextrading/p/veeva-systems-trading-a-mission-critical?r=2bgp9u&utm_campaign=post-expanded-share&utm_medium=web
0 · Reply
TalkMarkets
TalkMarkets Jul. 1 at 8:11 PM
Analysis Of #Veeva’s Copli #Acquisition $VEEV https://talkmarkets.com/article/analysis-of-veevas-copli-acquisition-1782932319
0 · Reply
anvesti
anvesti Jul. 1 at 7:53 PM
Anvesti closed a long position $VEEV 🟢 +20.05% $154.29 → $185.22 Model: ml_model_v3 · Score: 82.2 Reason: Profit Target · 9 days
0 · Reply
DeepSeaTurtle
DeepSeaTurtle Jul. 1 at 7:34 PM
$VEEV Strong intraday rebound back above the 50-day and VWAP, showing early momentum recovery off oversold conditions. However, price is still well below the 200-day, so this remains a corrective rally within a broader downtrend rather than a full trend reversal. Key zones: 188–190 area: near-term stretch zone where rallies can stall 170–174: healthier pullback zone for continuation setups Above 200 with volume: would signal real trend repair For now, this is a bounce within a larger reset phase, not a confirmed new trend.
0 · Reply
Latest News on VEEV
Veeva price target lowered to $272 from $296 at JPMorgan

2026-06-25T10:55:36.000Z - 9 days ago

Veeva price target lowered to $272 from $296 at JPMorgan


Veeva Systems Transcript: AGM 2026

Jun 17, 2026, 12:00 PM EDT - 17 days ago

Veeva Systems Transcript: AGM 2026


Veeva price target lowered to $270 from $295 at Mizuho

2026-06-04T13:32:10.000Z - 4 weeks ago

Veeva price target lowered to $270 from $295 at Mizuho


Veeva price target lowered to $235 from $300 at TD Cowen

2026-06-04T12:49:03.000Z - 4 weeks ago

Veeva price target lowered to $235 from $300 at TD Cowen

CRM


Veeva price target lowered to $185 from $240 at Evercore ISI

2026-06-04T12:10:55.000Z - 4 weeks ago

Veeva price target lowered to $185 from $240 at Evercore ISI


Veeva price target lowered to $190 from $220 at UBS

2026-06-04T12:01:26.000Z - 4 weeks ago

Veeva price target lowered to $190 from $220 at UBS


Veeva price target lowered to $175 from $220 at BMO Capital

2026-06-04T11:55:38.000Z - 4 weeks ago

Veeva price target lowered to $175 from $220 at BMO Capital


Veeva price target lowered to $230 from $245 at Stifel

2026-06-04T11:26:26.000Z - 4 weeks ago

Veeva price target lowered to $230 from $245 at Stifel


Veeva price target raised to $260 from $250 at Baird

2026-06-04T11:06:02.000Z - 4 weeks ago

Veeva price target raised to $260 from $250 at Baird


Veeva price target lowered to $220 from $235 at Canaccord

2026-06-04T10:50:29.000Z - 4 weeks ago

Veeva price target lowered to $220 from $235 at Canaccord


Veeva price target raised to $320 from $317 at Wells Fargo

2026-06-04T10:44:26.000Z - 4 weeks ago

Veeva price target raised to $320 from $317 at Wells Fargo


Veeva price target lowered to $235 from $285 at Piper Sandler

2026-06-04T10:43:00.000Z - 4 weeks ago

Veeva price target lowered to $235 from $285 at Piper Sandler


Veeva price target lowered to $165 from $190 at Goldman Sachs

2026-06-04T10:20:10.000Z - 4 weeks ago

Veeva price target lowered to $165 from $190 at Goldman Sachs


Veeva price target raised to $190 from $176 at Citi

2026-06-04T10:15:39.000Z - 4 weeks ago

Veeva price target raised to $190 from $176 at Citi


Veeva price target lowered to $235 from $250 at Barclays

2026-06-04T09:20:10.000Z - 4 weeks ago

Veeva price target lowered to $235 from $250 at Barclays


Veeva reported ‘solid’ Q1 results, says Truist

2026-06-04T00:06:02.000Z - 4 weeks ago

Veeva reported ‘solid’ Q1 results, says Truist


Veeva Systems Earnings Call Transcript: Q1 2027

Jun 3, 2026, 5:00 PM EDT - 4 weeks ago

Veeva Systems Earnings Call Transcript: Q1 2027


Veeva Systems Earnings release: Q1 2027

Jun 3, 2026, 5:00 PM EDT - 4 weeks ago

Veeva Systems Earnings release: Q1 2027


Veeva Systems Slides: Q1 2027

Jun 3, 2026, 5:00 PM EDT - 4 weeks ago

Veeva Systems Slides: Q1 2027


Veeva Systems Quarterly report: Q1 2027

Jun 3, 2026, 5:00 PM EDT - 4 weeks ago

Veeva Systems Quarterly report: Q1 2027


Veeva Announces Fiscal 2027 First Quarter Results

Jun 3, 2026, 4:05 PM EDT - 4 weeks ago

Veeva Announces Fiscal 2027 First Quarter Results


Teva Pharmaceuticals Commits to Veeva Vault CRM

May 27, 2026, 7:03 AM EDT - 5 weeks ago

Teva Pharmaceuticals Commits to Veeva Vault CRM


Veeva Systems Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 2 months ago

Veeva Systems Proxy statement: Proxy filing


Veeva Systems Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 2 months ago

Veeva Systems Proxy statement: Proxy filing


Veeva Systems to join S&P 500 index, replacing Coterra Energy

Apr 30, 2026, 6:40 PM EDT - 2 months ago

Veeva Systems to join S&P 500 index, replacing Coterra Energy


Veeva Systems Set to Join S&P 500

Apr 30, 2026, 6:23 PM EDT - 2 months ago

Veeva Systems Set to Join S&P 500

CTRA DVN


Veeva Systems Earnings Call Transcript: Q4 2026

Mar 4, 2026, 5:00 PM EST - 4 months ago

Veeva Systems Earnings Call Transcript: Q4 2026


Veeva Systems Annual report: Q4 2026

Mar 4, 2026, 5:00 PM EST - 4 months ago

Veeva Systems Annual report: Q4 2026


Veeva Systems Earnings release: Q4 2026

Mar 4, 2026, 5:00 PM EST - 4 months ago

Veeva Systems Earnings release: Q4 2026


Veeva Systems Slides: Q4 2026

Mar 4, 2026, 5:00 PM EST - 4 months ago

Veeva Systems Slides: Q4 2026


Veeva Announces Fourth Quarter and Fiscal Year 2026 Results

Mar 4, 2026, 4:05 PM EST - 4 months ago

Veeva Announces Fourth Quarter and Fiscal Year 2026 Results


Veeva to Present at the J.P. Morgan 2026 Healthcare Conference

Jan 8, 2026, 4:05 PM EST - 6 months ago

Veeva to Present at the J.P. Morgan 2026 Healthcare Conference


Veeva and BioMarin Form Long-Term Strategic Partnership

Jan 8, 2026, 8:30 AM EST - 6 months ago

Veeva and BioMarin Form Long-Term Strategic Partnership

BMRN


Veeva Announces Share Repurchase Program

Jan 5, 2026, 4:35 PM EST - 6 months ago

Veeva Announces Share Repurchase Program


Veeva to Present at Upcoming Investor Conference

Dec 4, 2025, 4:05 PM EST - 7 months ago

Veeva to Present at Upcoming Investor Conference


Veeva Announces Expanded Partnership with Roche

Nov 24, 2025, 7:03 AM EST - 7 months ago

Veeva Announces Expanded Partnership with Roche


Veeva Systems Earnings Call Transcript: Q3 2026

Nov 20, 2025, 5:00 PM EST - 8 months ago

Veeva Systems Earnings Call Transcript: Q3 2026


Veeva Systems Quarterly report: Q3 2026

Nov 20, 2025, 5:00 PM EST - 8 months ago

Veeva Systems Quarterly report: Q3 2026


Veeva Systems Earnings release: Q3 2026

Nov 20, 2025, 5:00 PM EST - 8 months ago

Veeva Systems Earnings release: Q3 2026


Veeva Systems Slides: Q3 2026

Nov 20, 2025, 5:00 PM EST - 8 months ago

Veeva Systems Slides: Q3 2026


Veeva Announces Fiscal 2026 Third Quarter Results

Nov 20, 2025, 4:05 PM EST - 8 months ago

Veeva Announces Fiscal 2026 Third Quarter Results


Veeva Systems Transcript: Investor Day 2025

Oct 16, 2025, 4:30 PM EDT - 9 months ago

Veeva Systems Transcript: Investor Day 2025


Veeva Systems Slides: FY 2025

Oct 16, 2025, 4:30 PM EDT - 9 months ago

Veeva Systems Slides: FY 2025


OpenEvidence and Veeva Announce Open Vista Partnership

Oct 16, 2025, 10:00 AM EDT - 9 months ago

OpenEvidence and Veeva Announce Open Vista Partnership


Veeva AI Agents to Be Released Across All Veeva Applications

Oct 14, 2025, 10:03 AM EDT - 9 months ago

Veeva AI Agents to Be Released Across All Veeva Applications


Big Money Boost – Veeva Up 975% Since 2015

Oct 10, 2025, 7:01 AM EDT - 9 months ago

Big Money Boost – Veeva Up 975% Since 2015


Final Trades: Veeva Systems, PG&E, Conagra Brands, and EQT

Oct 7, 2025, 1:21 PM EDT - 9 months ago

Final Trades: Veeva Systems, PG&E, Conagra Brands, and EQT

CAG PCG EQT


How to trade the health care break out

Oct 6, 2025, 2:24 PM EDT - 9 months ago

How to trade the health care break out

MCK MRK UNH XBI XLV


Josh Brown's 'Best Stocks in the Market': Veeva Systems

Oct 3, 2025, 2:00 PM EDT - 9 months ago

Josh Brown's 'Best Stocks in the Market': Veeva Systems


Veeva to Host Virtual Investor Day on October 16, 2025

Sep 25, 2025, 4:05 PM EDT - 10 months ago

Veeva to Host Virtual Investor Day on October 16, 2025


Bristol Myers Squibb Commits to Veeva Vault CRM

Sep 22, 2025, 10:03 AM EDT - 10 months ago

Bristol Myers Squibb Commits to Veeva Vault CRM


Gilead Sciences Commits to Veeva Vault CRM

Sep 10, 2025, 10:03 AM EDT - 10 months ago

Gilead Sciences Commits to Veeva Vault CRM


donkeykongreturns
donkeykongreturns Jul. 3 at 4:39 AM
$VEEV An AI MLR tool is interesting, but adoption seems unlikely. MLR teams carrying significant compliance weight with FDA regs attached to literally every single word and image they review. 'Speed' is not the goal - accuracy and documentation are. Falcon MLR sounds like a release for the sake of having something to release. Copli is a different matter. That's a good idea (others have done it - not well) that Veeva specifically can execute on because of their MLR and Vault products. They house the content. This might be Veeva's competitive advantage post the complete ass kicking that IQVIA gave Veeva when they snatched the CRM market from them. Still think it ran to top of the range too quick, but Copli is interresting now that Veeva is no longer in the running for CRM. Their next few years are coming into focus.
0 · Reply
oceanbleu
oceanbleu Jul. 2 at 8:24 PM
$VEEV I alerted for a long at 168$ late last week and it is now up 14% from entry . The target 1 of 226.6$ is in sight. but first the daily 197.6 level must be breached and it can potentially still retest weekly accumulation zone as long as that pivot holds.
0 · Reply
IncelBull
IncelBull Jul. 2 at 7:46 PM
$LULU yogapants up along with $MELI $VEEV $PYPL $ADBE
0 · Reply
JFDI
JFDI Jul. 2 at 6:58 PM
$VEEV some strength off the lows
1 · Reply
Damiano18
Damiano18 Jul. 2 at 6:28 PM
$VEEV I love veev
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:43 PM
0 · Reply
lextrading
lextrading Jul. 2 at 3:35 PM
$VEEV since these alerts, it will be up almost 35% at the $203 pivot. I win. https://open.substack.com/pub/lextrading/p/veeva-systems-trading-a-mission-critical?r=2bgp9u&utm_campaign=post-expanded-share&utm_medium=web
0 · Reply
TalkMarkets
TalkMarkets Jul. 1 at 8:11 PM
Analysis Of #Veeva’s Copli #Acquisition $VEEV https://talkmarkets.com/article/analysis-of-veevas-copli-acquisition-1782932319
0 · Reply
anvesti
anvesti Jul. 1 at 7:53 PM
Anvesti closed a long position $VEEV 🟢 +20.05% $154.29 → $185.22 Model: ml_model_v3 · Score: 82.2 Reason: Profit Target · 9 days
0 · Reply
DeepSeaTurtle
DeepSeaTurtle Jul. 1 at 7:34 PM
$VEEV Strong intraday rebound back above the 50-day and VWAP, showing early momentum recovery off oversold conditions. However, price is still well below the 200-day, so this remains a corrective rally within a broader downtrend rather than a full trend reversal. Key zones: 188–190 area: near-term stretch zone where rallies can stall 170–174: healthier pullback zone for continuation setups Above 200 with volume: would signal real trend repair For now, this is a bounce within a larger reset phase, not a confirmed new trend.
0 · Reply
gimmemoremobileye
gimmemoremobileye Jul. 1 at 4:35 PM
$VEEV compelling and undervalued earnings and guidance as well as margins look great I’m in
0 · Reply
Luke81c
Luke81c Jul. 1 at 3:37 PM
$VEEV This stock just deserves it.
0 · Reply
CatRocks
CatRocks Jul. 1 at 2:28 PM
$VEEV 200 soon?
0 · Reply
lextrading
lextrading Jul. 1 at 2:23 PM
$VEEV Position is up double digit now. Watching for profit takers as we approach 2 key pivots. Fractal is also tracking. Will consider selling covered calls at the peak to profit off the volatility. Long.
0 · Reply
Diplo_Squeezer
Diplo_Squeezer Jul. 1 at 1:32 PM
$OC $VEEV I’m really too good at this. Kids college is paid for now! Fk anyone whoever looked over my posts. They rest 🥂
0 · Reply
billyl
billyl Jul. 1 at 1:22 PM
$VEEV a beautiful AI story… revenue projections increase 6x to 6B by 2030 yeah babes
0 · Reply
billyl
billyl Jul. 1 at 1:18 PM
$VEEV 6 X increases in Rev from +890m to 6B by 2030…. With AI reducing operating costs… Future Guidance Q2 FY2027 Outlook: Total revenue is expected to be between $902 and $905 million with a non-GAAP EPS between $2.21 and $2.22. Raised Full-Year FY2027 Outlook: Total Revenue: Lifted to $3.635 – $3.645 billion (up from previous guidance of ~$3.59B). Non-GAAP EPS: Raised to approximately $9.05 (up from prior expectations of ~$8.85). Long-Term Goal: Management reiterated confidence in achieving a $6 billion revenue run-rate target by 2030.
0 · Reply
billyl
billyl Jul. 1 at 1:13 PM
$VEEV 2 of 2 Strategic & Product Milestones AI Pivot & Agentic Labor: Management emphasized its accelerated industry AI strategy. It highlighted the acquisition of Ostro (conversational AI live across 50 brands) and introduced Veeva Falcon, an upcoming agentic AI product tailored to automate up to 70% of manual medical, legal, and regulatory (MLR) review labor over the next five years. Vault CRM Traction: Veeva added 27 new Vault CRM customers in the quarter, bringing its total to over 150 live customers. The Salesforce Migration Battle: Management pointed out high win rates in the competitive space, stating they have secured 10 of the tracked top-20 enterprise CRM decisions this year, compared to 6 for Salesforce.
0 · Reply
billyl
billyl Jul. 1 at 1:12 PM
$VEEV viva lesvega!! Financial Highlights 1 of 2 Total Revenue: $882.9 million, up 16% year-over-year (YoY), beating consensus estimates of roughly $870.7 million. Subscription Revenue: $730.2 million, growing 15% YoY, continuing to make up the vast majority of Veeva's business. Earnings Per Share (EPS): Non-GAAP fully diluted EPS came in at $2.24, up from $1.97 in the same period last year, beating analyst estimates of $2.02–$2.17. Operating Margins: Non-GAAP operating income reached $395.4 million (up 13% YoY), underscoring a strong profitable profile with a non-GAAP operating margin near 45%. Net Income: Non-GAAP net income was $371.1 million, compared to $327.8 million in Q1 last year.
0 · Reply
Ziggy11
Ziggy11 Jul. 1 at 10:32 AM
$CRM target $225 $VEEV $WDAY $ADBE $INTU and APP many others
0 · Reply
JFDI
JFDI Jun. 29 at 2:36 PM
$VEEV pocket of space from here to 210/200d
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 28 at 7:11 AM
$VEEV Veeva Systems Inc. (VEEV) is bringing AI into one of the most painful parts of life sciences: medical, legal, and regulatory content review. With Veeva Falcon MLR, the company says it could eliminate more than 70% of manual MLR work over five years. https://biotechhealthx.com/biotech-news/is-veeva-veev-a-smart-stock-to-buy-as-healthcare-goes-digital/
0 · Reply